Industry Executive, Molly S. McGlaughlin, Named Chief Operating Officer of Azzur Cleanrooms on Demand™
BioPharma
Stay updated with breaking news from Vigene Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Azzur Group, a market-leading provider for life science GxP services, today announces the appointment of Molly McGlaughlin to Chief Operating...
PUNE, India, Oct. 15, 2021 /PRNewswire/ -- According to The Insight Partners study on "Contract Research Organization (CRO) Market to 2028 - Global Analysis and Forecast - by Type, End User
Charles River Labs buys Maryland firm for $292m The Wilmington-based drug research company is acquiring Vigene Biosciences, a gene therapy contract development and manufacturing organization. By Jonathan Saltzman Globe Staff,Updated May 17, 2021, 1 hour ago Email to a Friend Inside Charles River Labs in Wilmington.The Boston Globe/Boston Globe Charles River Laboratories, the Wilmington-based drug research company, said Monday it has signed a deal to buy Vigene Biosciences, a Maryland gene therapy contract development and manufacturing organization, for $292.5 million. The deal comes three m...